Posted by Michael Wonder on 25 Aug 2022
Novavax vaccine for adolescents aged 12-17 years
25 August 2022 - The Australian Technical Advisory Group on Immunisation has evaluated data on immunogenicity, efficacy, safety, and international recommendations to make recommendations on the use of Novavax COVID-19 vaccine in this age group.
The Australian Government has accepted advice from the Australian Technical Advisory Group on Immunisation that adolescents aged 12-17 years can receive the Novavax COVID-19 vaccine for their primary course of COVID-19 vaccination.
